Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT00560794

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Julius-Maximilians-Universität Würzburg Würzburg, Bavaria, Germany
  • Klinikum der J.W. Goethe Universität Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Münster Münster, North Rhine-Westphalia, Germany
View Trial Details
Completed

Extension Program for Bay 43-9006

NCT00657254

Conditions
Metastasis, Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • Boston, Massachusetts, United States
  • Bruxelles - Brussel, Belgium
  • Hamilton, Ontario, Canada
  • Toronto, Ontario, Canada
View Trial Details
Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions
Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • Princess Margaret Hospital Cashmere, Canterbury, New Zealand
View Trial Details

Related conditions